Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) took steps on Friday, May 29th, 2020,  to further support the development of COVID-19 Coronavirus tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website.

[Read more]

FDA Coronavirus (COVID-19) Update for April 1st, 2020

Silver Spring, MD – Last Wednesday, April 1st, 2020, the U.S. Food and Drug Administration (FDA) announced the following actions taken in its ongoing response effort to the Coronavirus (COVID-19) pandemic.

FDA-ARGOS SARS-CoV-2 Reference Grade Sequence Data Now Available: In response to the Coronavirus (COVID-19) pandemic, the FDA—in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), the Biodefense and Emerging Infections Research Resources Repository (BEI Resources) and the Institute for Genome Sciences at the University of Maryland and the National Center for Biotechnology Information (NCBI)—developed quality-controlled, reference sequence data for the SARS-CoV-2 reference strain for the United States.

[Read more]